Skip to content
Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

10.46243/jst.2021.v6.i2.pp58-63 registered

Review on Defensive Roles of Thymoquinone NanobiosensoringProspective in Opposition to Cancer

Resolves to https://www.jst.org.in/index.php/pub/article/view/301

Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2021.v6.i2.pp58-63

Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 0508cc7a8d14b064…

Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)

Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).

What the DOI identifies

JournalArticle — an article in a journal · Digital · Visual · en

Review on Defensive Roles of Thymoquinone NanobiosensoringProspective in Opposition to Cancer (PrincipalTitle · en)

Published 2021-02-03

Part of Journal of Science & Technology · ISSN 2456-5660 · volume 06 · issue 02 · pages 58–63

Agents

Identifiers DOI 10.46243/jst.2021.v6.i2.pp58-63

Abstract · en

Thymoquinone (TQ), the most important bioactive constituent of Nigella sativa, has been originating to exhibit anticancer effects in plentiful preclinical studies. Due to its multi targeting character, TQ interferes in an extensive assortment of tumorigenic processes and counteracts carcinogenesis, malicious growth, incursion, exodus, and angiogenesis. Moreover, TQ can exclusively sensitize tumor cells on the way to predictable cancer treatments (e.g.,chemotherapy, immunotherapy, and radiotherapy) and at the same time lessen psychoanalysis connected lethal effects in regular cells. In this review, we summarized the adjuvant prospective of TQ as observed in an assortment ofin vitroandin vivoanimal models and discussed the pharmacological properties of TQ to diminish its additional role in potentiating the usefulness of usual remedial modalities specifically surgery, radiotherapy, chemotherapy, and immunotherapy. On the whole we suggest supplementary ample evaluation of TQ in preclinical and clinical levels to demarcate its obscure usefulness as a novel corresponding adjuvant remedy for cancer treatment.

Licence https://creativecommons.org/licenses/by/4.0/

System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1

Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.

ElementValueIn the record
DOI Name
DOI name
10.46243/jst.2021.v6.i2.pp58-63doi
Referent Type
referentType
Creationreferent
Referent Sub-Type
referentSubType
JournalArticle — an article in a journaltype
Referent Name(s)
referentName(s)
Review on Defensive Roles of Thymoquinone NanobiosensoringProspective in Opposition to Cancer (PrincipalTitle, en)titles
Basic Metadata
basicMetadata
author: Dr.A. Mohamed Sikkander
author: Dr.Khadeeja Yasmeen
publisher: Longman Publishers
published: 2021-02-03
part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 06 · no. 02 · pp. 58–63
language: en
form: Digital · Visual · Language
agents, dates, container, language, structural_type, modes, characters
Referent Identifier(s)
alternateIdentifier(s)
none besides the DOIidentifiers, relations (IsSameAs)
Registration Authority
registrationAuthorityCode
Crossref — issued by Crossref (member 25296); held here as a copyrecord.source_agency (our code, ra_doi_name, for names issued here once appointed)
Created Date
issueDate
2026-09-08record.registered (when the DOI name was first registered)
relatedIdentifiersnone needed — the descriptive metadata is in this recordcontainer, relations (only where the descriptive metadata lives at another identifier)

complete Every System Metadata element is here, with the basic metadata a journal article needs.

The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs

Cited by — in this registry

No record held in this registry cites this DOI.

Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON

References with DOIs

The record lists 24 references; 21 carry a DOI.

#ReferenceDOIHeld here
2ref2 El-Far, A.H. Thymoquinone anticancer discovery: Possible mechanisms. Curr. Drug Discov. Technol. 2015, 12, 80–89. [CrossRef] [PubMed]10.2174/1570163812666150716111821not held here
3ref3 El-Far, A.H.; Korshom, M.A.; Mandour, A.A.; El-Bessoumy, A.A.; El-Sayed, Y.S. Hepatoprotective efficacy of Nigella sativa seeds dietary supplementation against lead acetate-induce…10.1016/j.biopha.2017.02.044not held here
4ref4 Banerjee, S.; Padhye, S.; Azmi, A.; Wang, Z.W.; Philip, P.A.; Kucuk, O.; Sarkar, F.H.; Mohammad, R.M. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr…10.1080/01635581.2010.509832not held here
5ref5 Darakhshan, S.; Pour, A.B.; Colagar, A.H.; Sisakhtnezhad, S. Thymoquinone and its therapeutic potentials. Pharmacol. Res. 2015, 95–96, 138–158. [CrossRef] [PubMed]10.1016/j.phrs.2015.03.011not held here
6ref6 Salmani, J.M.; Asghar, S.; Lv, H.X.; Zhou, J.P. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and l…10.3390/molecules19055925not held here
7ref7 Alkharfy, K.M.; Ahmad, A.; Khan, R.M.; Al-Shagha, W.M. Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model. Eur. J. Drug Met…10.1007/s13318-014-0207-8not held here
8ref8 Schneider-Stock, R.; Fakhoury, I.H.; Zaki, A.M.; El-Baba, C.O.; Gali-Muhtasib, H.U. Thymoquinone: Fifty years of success in the battle against cancer models. Drug Discov. Today 20…10.1016/j.drudis.2013.08.021not held here
9ref9 Ballout, F.; Habli, Z.; Rahal, O.N.; Fatfat, M.; Gali-Muhtasib, H. Thymoquinone-based nanotechnology for cancer therapy: Promises and challenges. Drug Discov. Today 2018, 23, 1089…10.1016/j.drudis.2018.01.043not held here
10ref10 Gupta, B.; Ghosh, K.K. Thymoquinone. In Nutraceuticals: Efficacy, Safety and Toxicity; Gupta, R.C., Ed.; Elsevier: Boston, MA, USA, 2016; pp. 541–55010.1016/b978-0-12-802147-7.00039-5not held here
11ref11 Imran, M.; Rauf, A.; Khan, I.A.; Shahbaz, M.; Qaisrani, T.B.; Fatmawati, S.; Abu-Izneid, T.; Imran, A.; Ur Rahman, K.; Gondal, T.A. Thymoquinone: A novel strategy to combat cancer…10.1016/j.biopha.2018.06.159not held here
13ref13 Srinivas, P.R.; Philbert, M.; Vu, T.Q.; Huang, Q.; Kokini, J.L.; Saltos, E.; Chen, H.; Peterson, C.M.; Friedl, K.E.; McDade-Ngutter, C.; et al. Nanotechnology research: Applicatio…10.3945/jn.109.115048not held here
14ref14 Li, W.; Yalcin, M.; Lin, Q.; Ardawi, M.M.; Mousa, S.A. Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery. J. Control. Release 2017, 248, …10.1016/j.jconrel.2017.01.009not held here
15ref15 Weiss, J.; Takhistov, P.; McClements, D.J. Functional materials in food nanotechnology. J. Food Sci. 2006, 71, R107–R116. [CrossRef] 62 | Page10.1111/j.1750-3841.2006.00195.xnot held here
16ref16 Nihei, T.; Suzuki, H.; Aoki, A.; Yuminoki, K.; Hashimoto, N.; Sato, H.; Seto, Y.; Onoue, S. Development of a novel nanoparticle formulation of thymoquinone with a cold wet-milling…10.1016/j.ijpharm.2016.07.038not held here
17ref17 Zamboni, W.C. Concept and clinical evaluation of carrier-mediated anticancer agents. Oncologist 2008, 13, 248–260. [CrossRef] [PubMed]10.1634/theoncologist.2007-0180not held here
18ref18 Gali-Muhtasib H, Ocker M, Kuester D, Krueger S, El-Hajj Z, et al. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. J C…10.1111/j.1582-4934.2007.00095.xnot held here
19ref19 Badary OA, Al-Shabanah OA, Nagi MN, Al-Rikabi AC, Elmazar MM. Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone. Eur J Cancer Prev. 1999;8:43…10.1097/00008469-199910000-00009not held here
21ref21 Badary OA, Nagi MN, al-Shabanah OA, al-Sawaf HA, al-Sohaibani MO, et al. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor …10.1139/y97-169not held here
22ref22 Badary OA. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol. 1999;67:135–14210.1016/s0378-8741(98)00242-6not held here
23ref23 Kaseb AO, Chinnakannu K, Chen D, Sivanandam A, Tejwari S, et al. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res. 2007…10.1158/0008-5472.can-07-1483not held here
24ref24 Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 2009;11:373–…10.1111/j.1477-2574.2009.00059.xnot held here

The references as JSON

Relations

The record states no relation, and no record held here states one with this DOI.

The relations as JSON

Funding

The record names no funder.

Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.

History — the ledger

Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.

#WhenWhatByChanges
129 Sep 2026, 10:00 PMregister
registered at Crossref; record read from api.crossref.org
Administrator (admin) 128 fields set · sha256 2a3ab169f6a3…
229 Sep 2026, 11:59 PMupdate
record re-read from api.crossref.org
Administrator (admin)
container.titles.0.value: Journal of Science & Technology → Journal of Science & Technology

Machine-readable: the history as JSON, with the full record after each change.

Changes made at Crossref through DOI Doctor

Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.

WhenWhat changedCrossrefFingerprint
11 Sep 2026, 05:18Address updated
from https://www.jst.org.in/index.php/pub/article/view/301/264 to https://www.jst.org.in/index.php/pub/article/view/301
● accepted by Crossrefb85e1bbec973…
13 Sep 2026, 01:40Read back: the DOI resolves to the new address● confirmed445c399c81ca…
15 Oct 2026, 15:30Metadata completed
abstract (152 words) · licence
● accepted by Crossrefcc5cfcb7afe5…
15 Oct 2026, 16:19Read back: Crossref's record shows it● confirmedba15c0ed4bbc…

4 entries · the last fingerprint ba15c0ed4bbccca2780835b43d6eadfd571c3fe9f3eded711492e351fff32b4b · the history as JSON, each entry with the fingerprint before it, to check them yourself.

Share this page

Share this page

Ask AI about this page

Everything Smart Scholars runs

Nine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

What we do: DOIs registered from what a journal already has · Crossref records completed — references, abstracts, licences, ORCID iDs, affiliations and ROR IDs, funding · DOIs that resolve · articles preserved · journals rated on the public record · see everything we do →

Book a free call

For journals & publishers

Start with the audit — ₹4,999 per journal, and the gate to everything else.

DOI care

Every service on one journal profile — each previews first and acts only on your approval.

  • DOI Doctor — check & repairevery DOI tested at doi.org and Crossref; dead links, abstracts, licences, ORCIDs
  • Smart Deposita new DOI from your PDF, Word file, article page, JATS XML or spreadsheet — every value shown with its source, deposited once you confirm it
  • DOI census (Excel)site against Crossref, both directions, with a copy-paste fix per article
  • Backfile DOIsDOIs for older articles that never had one — no per-DOI fee of ours
  • DOIs for conference proceedingsthe conference, the volume and every paper — registered in the organiser's own name
  • Scopus indexing guidethe minimum criteria, the 14 CSAB criteria and how a title is suggested — from Elsevier's own page
  • Embase indexing guidewhat Embase asks of a biomedical journal and how to suggest it
  • Write DOIs into OJSthe verified DOIs pushed onto your article pages through your own API
  • Silent-failure monitorweekly checks of site, OAI-PMH, Scholar tags, ISSN, preservation, hijack lists
  • Journal Radarevery journal, every day: SSL, DNS, redirects, robots.txt, OJS, DOIs, Crossref metadata, broken links — what broke since yesterday first
  • Verified metrics & badgesa public, dated, source-linked metrics page and a "cited by" badge
  • Quality dossier (PDF)one PDF for universities, authors and reviewers
  • Author citation enginethe citation steps emailed to each author from the journal's own mailbox
  • JATS XMLmachine-readable JATS per article
  • Duplicate articlesthe same paper published twice — you choose which copy stays

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.

Journals

  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content

Books & conferences

  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers

Other research output

  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements

Funding

  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Add Smart Scholars as a preferred source on GoogleSee more of our newsroom in Google’s Top Stories.
Smart Scholars · Every service on one pageNewsroom posts CC BY 4.0 · DOI metadata CC0 · everything else ©Data from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp